ApprovalTrail

Approval · Notice of Compliance 7974 · 2006

LORELCO: Notice of Compliance 7974

Issued May 18, 2006

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
7974
Date
May 18, 2006
Company
Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Admin
Reason
Manufacturer name change
Therapeutic class
Lipid metabolism regulator

Products in this notice

BrandDINStatus today
LORELCO02091909Cancelled Post Market

Medicinal ingredients